TRINITY BIOTECH PLC (TRIB)

Every figure this model derived for TRIB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 405,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-12-31
cash 5,167,000 CashAndCashEquivalents 2024-12-31
current assets 41,124,000 CurrentAssets 2024-12-31
current liabilities 32,095,000 CurrentLiabilities 2024-12-31
equity -35,181,000 Equity 2024-12-31
interest expense 9,565,000 FinanceCosts 2024-12-31
ocf -4,191,000 CashFlowsFromUsedInOperatingActivities 2024-12-31
revenue 61,555,000 Revenue 2024-12-31
sbc 1,316,000 AdjustmentsForSharebasedPayments 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up TRIB on one particular measure came for.

RatioValue
cash operating margin-31.91
current ratio1.28
current ratio reported1.28
dilution pct134.2
fcf margin-7.47
interest cover-2.21
operating margin-34.38
owner earnings margin-9.6
revenue growth8.31
revenue growth per share-53.75
rule of 40-26.07
sbc pct revenue2.14

What to be careful about

What this model itself distrusts about TRIB's figures. Written by the derivation as it ran, not added afterwards.